Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1990 1
1991 1
1992 1
2008 1
2009 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. N Engl J Med. 2021 Jul 29;385(5):395-405. doi: 10.1056/NEJMoa2104162. N Engl J Med. 2021. PMID: 34320285 Clinical Trial.
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.
Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG; Austrian Fulvestrant Registry. Bartsch R, et al. Breast Cancer Res Treat. 2009 May;115(2):373-80. doi: 10.1007/s10549-008-0132-0. Epub 2008 Jul 26. Breast Cancer Res Treat. 2009. PMID: 18661231 Clinical Trial.
MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma.
Marosi C, Heinz R, Steger G, Fortelny A, Chott A, Hanak H, Radaszkiewicz T, Baur M, Kreiner G, Schwarzinger I, et al. Marosi C, et al. Among authors: fortelny a. J Cancer Res Clin Oncol. 1992;118(4):314-7. doi: 10.1007/BF01208622. J Cancer Res Clin Oncol. 1992. PMID: 1374411 Clinical Trial.
[Pamidronate in the treatment of tumor-associated hypercalcemia].
Pecherstorfer M, Janisch S, Marosi C, Wogritsch C, Bosse C, Schratzberger W, Gerber E, Fortelny A, Lenzhofer R, Rainer H, et al. Pecherstorfer M, et al. Among authors: fortelny a. Klin Wochenschr. 1991 Oct 2;69(15):690-5. doi: 10.1007/BF01649438. Klin Wochenschr. 1991. PMID: 1795492 Clinical Trial. German.
[Erythropoietin in multiple myeloma].
Pecherstorfer M, Schmoranzer F, Vesely M, Fortelny A, Baumgartner G. Pecherstorfer M, et al. Among authors: fortelny a. Dtsch Med Wochenschr. 1990 Jul 13;115(28-29):1096-9. doi: 10.1055/s-2008-1065126. Dtsch Med Wochenschr. 1990. PMID: 2373040 German.
[Herpes encephalitis in Hodgkin's disease].
Heinz R, Fortelny A, Waldner R, Grisold W, Jellinger K. Heinz R, et al. Among authors: fortelny a. Dtsch Med Wochenschr. 1986 May 30;111(22):881-2. Dtsch Med Wochenschr. 1986. PMID: 3709364 German. No abstract available.